1. R. Bataller and D. A. Brenner, Liver fibrosis. J Clin Invest, 2005. 115(2): p. 209-18.
2. Liver European Association for Study Of and Higado Asociacion Latinoamericana Para El Estudio Del, EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol, 2015. 63(1): p. 237-64.
3. J. Perrault, D. B. Mcgill, B. J. Ott, et al., Liver biopsy: complications in 1000 inpatients and outpatients. Gastroenterology, 1978. 74(1): p. 103-6.
4. C. P. Strassburg and M. P. Manns, Approaches to liver biopsy techniques--revisited. Semin Liver Dis, 2006. 26(4): p. 318-27.
5. B. Maharaj, R. J. Maharaj, W. P. Leary, et al., Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet, 1986. 1(8480): p. 523-5.
6. A. Regev, M. Berho, L. J. Jeffers, et al., Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol, 2002. 97(10): p. 2614-8.
7. J. A. Marrero, L. M. Kulik, C. B. Sirlin, et al., Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology, 2018. 68(2): p. 723-750.
8. N. Daginawala, B. Li, K. Buch, et al., Using texture analyses of contrast enhanced CT to assess hepatic fibrosis. Eur J Radiol, 2016. 85(3): p. 511-7.
9. A. L. Simpson, L. B. Adams, P. J. Allen, et al., Texture analysis of preoperative CT images for prediction of postoperative hepatic insufficiency: a preliminary study. J Am Coll Surg, 2015. 220(3): p. 339-46.
10. M. Romero-Gomez, E. Gomez-Gonzalez, A. Madrazo, et al., Optical analysis of computed tomography images of the liver predicts fibrosis stage and distribution in chronic hepatitis C. Hepatology, 2008. 47(3): p. 810-6.
11. R. J. Gillies, P. E. Kinahan, and H. Hricak, Radiomics: Images Are More than Pictures, They Are Data. Radiology. 278(2): p. 563-77.
12. H. J. Aerts, E. R. Velazquez, R. T. Leijenaar, et al., Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun, 2014. 5: p. 4006.
13. J. C. Wang, R. Fu, X. W. Tao, et al., A radiomics-based model on non-contrast CT for predicting cirrhosis: make the most of image data. Biomark Res, 2020. 8: p. 47.
14. P. Bedossa and T. Poynard, An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology, 1996. 24(2): p. 289-93.
15. C. T. Wai, J. K. Greenson, R. J. Fontana, et al., A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology, 2003. 38(2): p. 518-26.
16. A. Vallet-Pichard, V. Mallet, B. Nalpas, et al., FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest. Hepatology, 2007. 46(1): p. 32-6.
17. J. J. M. Van Griethuysen, A. Fedorov, C. Parmar, et al., Computational Radiomics System to Decode the Radiographic Phenotype. Cancer Res, 2017. 77(21): p. e104-e107.
18. P. E. Shrout and J. L. Fleiss, Intraclass correlations: uses in assessing rater reliability. Psychol Bull, 1979. 86(2): p. 420-8.
19. M. Friedrich-Rust, M. F. Ong, S. Martens, et al., Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology, 2008. 134(4): p. 960-74.
20. Rm O’brien, A Caution Regarding Rules of Thumb for Variance Inflation Factors. Quality & Quantity, 2007. 41(5): p. 673-690.
21. J. Lambert, P. Halfon, G. Penaranda, et al., How to measure the diagnostic accuracy of noninvasive liver fibrosis indices: the area under the ROC curve revisited. Clin Chem, 2008. 54(8): p. 1372-8.
22. E. R. Delong, D. M. Delong, and D. L. Clarke-Pearson, Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics, 1988. 44(3): p. 837-45.
23. E. W. Steyerberg and A. J. Vickers, Decision curve analysis: a discussion. Med Decis Making, 2008. 28(1): p. 146-9.
24. E. Herrmann, V. De Ledinghen, C. Cassinotto, et al., Assessment of biopsy-proven liver fibrosis by two-dimensional shear wave elastography: An individual patient data-based meta-analysis. Hepatology, 2018. 67(1): p. 260-272.
25. S. Singh, S. K. Venkatesh, Z. Wang, et al., Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: a systematic review and meta-analysis of individual participant data. Clin Gastroenterol Hepatol, 2015. 13(3): p. 440-451 e6.
26. Easloffice Easloffice Eu European Association for the Study of the Liver. Electronic Address and Liver European Association for the Study of The, EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol, 2018. 69(1): p. 182-236.
27. H. Watanabe, M. Kanematsu, S. Goshima, et al., Staging hepatic fibrosis: comparison of gadoxetate disodium-enhanced and diffusion-weighted MR imaging--preliminary observations. Radiology, 2011. 259(1): p. 142-50.
28. L. Petitclerc, G. Sebastiani, G. Gilbert, et al., Liver fibrosis: Review of current imaging and MRI quantification techniques. J Magn Reson Imaging, 2017. 45(5): p. 1276-1295.
29. H. J. Park, S. S. Lee, B. Park, et al., Radiomics Analysis of Gadoxetic Acid-enhanced MRI for Staging Liver Fibrosis. Radiology, 2019. 290(2): p. 380-387.
30. J. H. Son, S. S. Lee, Y. Lee, et al., Assessment of liver fibrosis severity using computed tomography-based liver and spleen volumetric indices in patients with chronic liver disease. Eur Radiol, 2020. 30(6): p. 3486-3496.
31. K. Yasaka, H. Akai, A. Kunimatsu, et al., Deep learning for staging liver fibrosis on CT: a pilot study. Eur Radiol, 2018. 28(11): p. 4578-4585.
32. G. W. Ji, Y. D. Zhang, H. Zhang, et al., Biliary Tract Cancer at CT: A Radiomics-based Model to Predict Lymph Node Metastasis and Survival Outcomes. Radiology, 2019. 290(1): p. 90-98.
33. X. Xu, H. L. Zhang, Q. P. Liu, et al., Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and outcome in hepatocellular carcinoma. J Hepatol, 2019. 70(6): p. 1133-1144.
34. M. Lemoine, Y. Shimakawa, S. Nayagam, et al., The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa. Gut, 2016. 65(8): p. 1369-76.
35. X. J. Lu, X. H. Li, Z. X. Yuan, et al., Assessment of liver fibrosis with the gamma-glutamyl transpeptidase to platelet ratio: a multicentre validation in patients with HBV infection. Gut, 2018. 67(10): p. 1903-1904.
36. P. Angulo, J. M. Hui, G. Marchesini, et al., The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology, 2007. 45(4): p. 846-54.
37. K. Fujita, T. Nomura, A. Morishita, et al., Albumin-Bilirubin Score Differentiates Liver Fibrosis Stage and Hepatocellular Carcinoma Incidence in Chronic Hepatitis B Virus Infection: A Retrospective Cohort Study. Am J Trop Med Hyg, 2019. 101(1): p. 220-225.
38. K. Fujita, K. Oura, H. Yoneyama, et al., Albumin-bilirubin score indicates liver fibrosis staging and prognosis in patients with chronic hepatitis C. Hepatol Res, 2019. 49(7): p. 731-742.
39. S. Omura, S. Taguchi, S. Miyagawa, et al., Prognostic significance of the albumin-to-globulin ratio for upper tract urothelial carcinoma. BMC Urol, 2020. 20(1): p. 133.
40. G. Y. Lv, L. An, X. D. Sun, et al., Pretreatment albumin to globulin ratio can serve as a prognostic marker in human cancers: a meta-analysis. Clin Chim Acta, 2018. 476: p. 81-91.
41. C. C. Zhang, C. W. Zhang, H. Xing, et al., Preoperative Inversed Albumin-to-Globulin Ratio Predicts Worse Oncologic Prognosis Following Curative Hepatectomy for Hepatocellular Carcinoma. Cancer Manag Res, 2020. 12: p. 9929-9939.
42. J. Park, H. J. Kim, J. Kim, et al., Predictive value of serum albumin-to-globulin ratio for incident chronic kidney disease: A 12-year community-based prospective study. PLoS One, 2020. 15(9): p. e0238421.
43. X. R. Liu, Y. Y. Qi, Y. F. Zhao, et al., Albumin-to-globulin ratio (AGR) as a potential marker of predicting lupus nephritis in Chinese patients with systemic lupus erythematosus. Lupus, 2021. 30(3): p. 412-420.
44. J. T. Niedziela, B. Hudzik, B. Szygula-Jurkiewicz, et al., Albumin-to-globulin ratio as an independent predictor of mortality in chronic heart failure. Biomark Med, 2018. 12(7): p. 749-757.
45. G. Feng, K. I. Zheng, Y. Y. Li, et al., Machine learning algorithm outperforms fibrosis markers in predicting significant fibrosis in biopsy-confirmed NAFLD. J Hepatobiliary Pancreat Sci, 2021. 28(7): p. 593-603.
46. A. Huber, L. Ebner, J. T. Heverhagen, et al., State-of-the-art imaging of liver fibrosis and cirrhosis: A comprehensive review of current applications and future perspectives. Eur J Radiol Open, 2015. 2: p. 90-100.